2021. Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s59. DOI:https://doi.org/10.25251/skin.5.supp.59.